Clinical Trial Update: Ketek in CAP / AECB in Ambulatory Adult Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of Ketek (telithromycin) in ambulatory adults with community-acquired pneumonia or acute exacerbations of chronic bronchitis; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Exacerbation of Chronic Bronchitis

Drugs mentioned

• Ketek (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Community Acquired Pneumonia (CAP), Acute Exacerbation of Chronic Bronchitis (AECB) | Phase 4 | Status: COMPLETED